Latent tuberculosis infection: Screening and treatment in an urban setting

Journal of Community Health

Volumn 38, Issue 5, 2013, Pages 941-950

  Morano, Jamie P ^a   Walton, Mary R ^a   Zelenev, Alexei ^a   Bruce, R Douglas ^a   Altice, Frederick L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Directly observed therapy; Foreign born; Immigrant; Latent tuberculosis; Mobile health care; Self administered therapy

Indexed keywords

ISONIAZID; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; DIRECTLY OBSERVED THERAPY; FEMALE; HEALTH SERVICE; HUMAN; LATENT TUBERCULOSIS; MALE; MASS SCREENING; MIGRATION; MIXED INFECTION; ORGANIZATION AND MANAGEMENT; PREVENTIVE HEALTH SERVICE; SOCIOECONOMICS; STATISTICS; TUBERCULIN TEST; UNITED STATES; MIGRANT; STATISTICS AND NUMERICAL DATA;

ADULT; ANTITUBERCULAR AGENTS; COINFECTION; CONNECTICUT; DIRECTLY OBSERVED THERAPY; EMIGRANTS AND IMMIGRANTS; FEMALE; HUMANS; ISONIAZID; LATENT TUBERCULOSIS; MALE; MASS SCREENING; MOBILE HEALTH UNITS; SOCIOECONOMIC FACTORS; TUBERCULIN TEST; URBAN HEALTH SERVICES;

EID: 84884283121     PISSN: 00945145     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10900-013-9704-y     Document Type: Article

References (30)

1. World Health Organization. (2012). Global tuberculosis report 2012: Tuberculosis executive summary. Geneva: Switzerland.
2. Centers for Disease Control and Prevention. (2012). Trends in tuberculosis - United States, 2011. MMWR, 61(11), 181-189.
3. Jackman, S. (2000). Estimation and inference via Bayesian simulation: An introduction to Markov Chain Monte Carlo. American Journal of Political Science, 44, 375-404.
4. Hirsch-Moverman, Y.; Bethel, J.; Colson, P. W.; Franks, J.; El-Sadr, W. (2010). Predictors of latent tuberculosis infection treatment completion in the United States: An inner city experience. The International Journal of Tuberculosis and Lung Disease, 14(9), 1104-1111.
5. Lazar, C.; Sosa, L.; Lobato, M. (2008). Practices and policies of providers testing school-aged children for tuberculosis, Connecticut. Journal of Community Health, 2010(35), 495-499.
6. Guh, A.; Sosa, L.; Hadler, J. L.; Lobato, M. N. (2011). Missed opportunities to prevent tuberculosis in foreign-born persons, Connecticut, 2005-2008. The International Journal of Tuberculosis and Lung Disease, 15(8), 1044-1049.
7. Altice, F. L.; Maru, D. S.; Bruce, R. D.; Springer, S. A.; Friedland, G. H. (2007). Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: A prospective, randomized, controlled trial. Clinical Infectious Diseases, 45(6), 770-778.
8. Macalino, G. E.; Hogan, J. W.; Mitty, J. A.; Bazerman, L. B.; Delong, A. K.; Loewenthal, H.; et al. (2007). A randomized clinical trial of community-based directly observed therapy as an adherence intervention for HAART among substance users. AIDS, 21(11), 1473-1477.
9. Berg, K. M.; Litwin, A.; Li, X.; Heo, M.; Arnsten, J. H. (2011). Directly observed antiretroviral therapy improves adherence and viral load in drug users attending methadone maintenance clinics: A randomized controlled trial. Drug and Alcohol Dependence, 113(2-3), 192-199.
10. Bruce, R.; Eiserman, J.; Acosta, A.; Gote, C.; Lim, J.; Altice, F. (2012). Developing a modified directly observed therapy intervention for hepatitis C treatment in a methadone maintenance treatment program: Implications for program replication. American Journal of Drug and Alcohol Abuse, 38(3), 206-212.
11. Enders, C. (2010). Applied missing data analysis. New York: Guilford Press.
12. Liebman, J.; Lamberti, P.; Altice, F. (2002). Effectiveness of a mobile medical van in providing screening services for STDs and HIV. Public Health Nursing, 19(5), 345-353.
13. Altice, F. L.; Bruce, R. D.; Walton, M. R.; Buitrago, M. I. (2005). Adherence to hepatitis B virus vaccination at syringe exchange sites. Journal of Urban Health, 82(1), 151-161.
14. Weiss, L.; Netherland, J.; Egan, J. E.; Flanigan, T. P.; Fiellin, D. A.; Finkelstein, R.; et al. (2011). Integration of buprenorphine/naloxone treatment into HIV clinical care: Lessons from the BHIVES collaborative. Journal of Acquired Immune Deficiency Syndromes, 56(S1), S68-S75.
15. Altice, F. L.; Bruce, R. D.; Lucas, G. M.; Lum, P. J.; Korthuis, P. T.; Flanigan, T. P.; et al. (2011). HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: Results from a multisite study. Journal of Acquired Immune Deficiency Syndromes, 56(S1), S22-S32.
16. Springer, S. A.; Chen, S.; Altice, F. L. (2010). Improved HIV and substance abuse treatment outcomes for released HIV-infected prisoners: The impact of buprenorphine treatment. Journal of Urban Health, 87(4), 592-602.
17. Sullivan, L. E.; Bruce, R. D.; Altice, F. L.; Haltiwanger, D.; Lucas, G. M.; Eldred, L.; et al. (2006). Initial strategies for integrating buprenorphine into HIV care settings in the United States. Clinical Infectious Diseases, 43(S4), S191-S196.
18. Schwarz, R. K.; Bruce, R. D.; Ball, S. A.; Herme, M.; Altice, F. L. (2009). Comparison of tuberculin skin testing reactivity in opioid-dependent patients seeking treatment with methadone versus buprenorphine: Policy implications for tuberculosis screening. American Journal of Drug and Alcohol Abuse, 35(6), 439-444.
19. Maru, D. S.; Bruce, R. D.; Walton, M.; Springer, S. A.; Altice, F. L. (2009). Persistence of virological benefits following directly administered antiretroviral therapy among drug users: Results from a randomized controlled trial. Journal of Acquired Immune Deficiency Syndromes, 50(2), 176-181.
20. Maru, D. S.; Bruce, R. D.; Walton, M.; Mezger, J. A.; Springer, S. A.; Shield, D.; et al. (2008). Initiation, adherence, and retention in a randomized controlled trial of directly administered antiretroviral therapy. AIDS and Behavior, 12(2), 284-293.
21. Altice, F. L.; Mezger, J. A.; Hodges, J.; Bruce, R. D.; Marinovich, A.; Walton, M.; et al. (2004). Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: Implications for program replication. Clinical Infectious Diseases, 38(S5), S376-S387.
22. Smith-Rohrberg, D.; Mezger, J.; Walton, M.; Bruce, R. D.; Altice, F. L. (2006). Impact of enhanced services on virologic outcomes in a directly administered antiretroviral therapy trial for HIV-infected drug users. Journal of Acquired Immune Deficiency Syndromes, 43(S1), S48-S53.
23. Saber-Tehrani A. S.; Springer S. A.; Qiu J.; Herme M.; Wickersham J.; Altice F. L. (2012). Rationale, study design and sample characteristics of a randomized controlled trial of directly administered antiretroviral therapy for HIV-infected prisoners transitioning to the community - a potential conduit to improved HIV treatment outcomes. Contemporary Clinical Trials, 33(2), 436-444.
24. World Health Organization. (2011). Guidelines for intensified tuberculosis case-finding and isoniazid preventative therapy for people living with HIV in resource-constrained settings. Geneva: Switzerland.
25. World Health Organization. (2011). Tuberculosis country profiles. http://www.who.int/tb/country/data/profiles/en/index.html. Accessed Nov 2012.
26. Stop TB Partnership. (2011). Global TB incidence rates. http://www.stoptb.org/assets/images/countries/map-incidence.jpg. Accessed Nov 2012.
27. StataCorp. (2011). Stata statistical software. College Station, TX: StataCorp LP.
28. Salomon, N.; Perlman, D.; Friedmann, P.; Perkins, M. P.; Ziluck, V.; Des Jarlais, D.; et al. (1999). Knowledge of tuberculosis among drug users relationship to return rates for tuberculosis screening at a syringe exchange. Journal of Substance Abuse Treatment, 16(3), 229-235.
29. Salomon, N.; Perlman, D.; Friedmann, P.; Ziluck, V.; Des Jarlais, D. (2000). Prevalence and risk factors for positive tuberculin skin tests among active drug users at a syringe exchange program. The International Journal of Tuberculosis and Lung Disease, 4(1), 47-54.
30. Sterling, T. R.; Villarino, M. E.; Borisov, A. S.; Shang, N.; Gordin, F.; Bliven-Sizemore, E.; et al. (2011). Three months of rifapentine and isoniazid for latent tuberculosis infection. The New England Journal of Medicine, 365(23), 2155-2166.